It is known that the TGF-β signaling pathway can promote tumor angiogenesis, induce invasion and metastasis by inducing the proliferation and survival of HCC cells and promoting epithelial–mesenchymal transformation (EMT), and create a favorable immune microenvironment for tumor growth to continuously promote tumor development (28). This evidence concerns the gene TGFB1 and neoplasm.